Philadelphia, PA · Founded 2018 · Privately Held (backing)
Developer of a protein drug platform designed to unlock the potential of genetic medicines. Aro Biotherapeutics is based in Philadelphia, PA and was founded in 2018. It was valued at $182 million at its later-stage round in Nov 2023, the last priced event on record. It has raised $132 million across 4 recorded rounds; the latest was a $24 million early-stage round in Dec 2022.
PMV mark · valuation
$181.5M
Oct 2026
Priced at
its later-stage round
Nov 2023
Total raised
$131.8M
Last round
Early Stage VC
Dec 2022
Cap table — not yet on record
Aro Biotherapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Aro Biotherapeutics with a free account
·Watch Aro Biotherapeutics: the Monday email on marks, rounds and moves
Where does Aro Biotherapeutics's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Aro Biotherapeutics's 4 recorded funding rounds.
